🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a 2-part, open-label, single-center relative bioavailabi...
Status
Completed
Location
Research Site
Start Date
2020-06-24
Trial ID
NCT04488016
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested
This phase II trial compares three chemotherapy regimens consisting of bend...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-12-13
Trial ID
NCT04115631
Treatments Being Tested
This is a global, multicenter, randomized, open-label, Phase III confirmato...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2024-04-07
Trial ID
NCT06319456
Treatments Being Tested
This study aims to evaluate the safety, tolerability, pharmacodynamic, and ...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital ( Site 0140)
Start Date
2017-06-26
Trial ID
NCT03162536
Treatments Being Tested
Study to determine the preliminary safety, tolerability, and pharmacokineti...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2021-03-02
Trial ID
NCT04419389
This study is to evaluate the effects of single therapeutic and supratherap...
Status
Completed
Location
Celerion
Start Date
2016-04-01
Trial ID
NCT04867980
Treatments Being Tested
This phase II trial studies the effects of acalabrutinib, umbralisib, and u...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2021-03-26
Trial ID
NCT04783415
Treatments Being Tested
This Phase 1 study is being conducted to support the clinical development o...
Status
Completed
Location
Research Site
Start Date
2020-10-12
Trial ID
NCT04564040
This phase II trial investigates how well modified VR-CAP (bortezomib, ritu...
Status
Active Not Recruiting
Location
Mount Sinai Hospital
Start Date
2021-08-03
Trial ID
NCT04626791